{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:55:07Z","timestamp":1793771707183,"version":"4.6.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00044-026-03610-w","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:11:19Z","timestamp":1787285479000},"page":"1722-1743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Review of promising benzimidazole-based anticancer agents (2023-2026)"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6618-5006","authenticated-orcid":false,"given":"Elena Y.","family":"Shumilova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1405-171X","authenticated-orcid":false,"given":"Sergey V.","family":"Sysolyatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3292-8336","authenticated-orcid":false,"given":"Svetlana V.","family":"Strokova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"3610_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13065-025-01623-x","volume":"19","author":"M Alhilal","year":"2025","unstructured":"Alhilal M, Alhila S, Gomha SM, Farag B, Sabancilar I, Ouf SA. Biological evaluation and molecular docking studies of novel aza-acyclic nucleosides as putative antimicrobial, anticancer, and antioxidant agents. BMC Chemistry. 2025;19:255 https:\/\/doi.org\/10.1186\/s13065-025-01623-x","journal-title":"BMC Chemistry"},{"key":"3610_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108728","volume":"163","author":"MO Aboelez","year":"2025","unstructured":"Aboelez MO, Ali MAEAA, Kamel MS, Fadaly WA, Nemr MT, Ezelarab HA. Novel 3, 4-diaminothieno [2, 3-b] thiophene-2, 5-dicarbohydrazide-based scaffolds as EGFRWT, EGFRT790M, and tubulin polymerization inhibitors with anti-proliferative activity. Bioorg Chem. 2025;163:108728 https:\/\/doi.org\/10.1016\/j.bioorg.2025.108728","journal-title":"Bioorg Chem"},{"key":"3610_CR3","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1080\/14756366.2022.2062338","volume":"37","author":"OM Aboelez","year":"2022","unstructured":"Aboelez OM, Belal A, Xiang G, Ma X. Design, synthesis, and molecular docking studies of novel pomalidomide-based PROTACs as potential anti-cancer agents targeting EGFRWT and EGFRT790M. J Enzyme Inhib Med Chem. 2022;37:1196\u2013211. https:\/\/doi.org\/10.1080\/14756366.2022.2062338","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3610_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140720","volume":"1324","author":"AM Ahmed","year":"2025","unstructured":"Ahmed AM, Aboelez MO, Ezelarab HA, Khodairy A, Hassan A, User MA, et al. New S-and N-alkyl functionalized bis-1, 2, 4-Triazolyl-based derivatives as potential dual EGFRWT and EGFRT790M inhibitors: Synthesis, anti-proliferative evaluation, molecular docking study and ADMET studies. J Mol Struct. 2025;1324:140720 https:\/\/doi.org\/10.1016\/j.molstruc.2024.140720","journal-title":"J Mol Struct"},{"key":"3610_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2026.109486","volume":"170","author":"SY Ewieda","year":"2026","unstructured":"Ewieda SY, Ahmed EM, Halim PA, Ibrahim SG, Gouda KM, Abdalla M, et al. Discovery of novel pyridazinone derivatives as EGFRWT\/ EGFRT790M kinase inhibitors; design, synthesis, antitumor evaluation, and molecular dynamic simulations. Bioorg Chem. 2026;170:109486 https:\/\/doi.org\/10.1016\/j.bioorg.2026.109486","journal-title":"Bioorg Chem"},{"key":"3610_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202500175","volume":"10","author":"M Abdalla","year":"2025","unstructured":"Abdalla M, Elmasry AE, Nemr MTM, Alanazi MM, Attallah NGM, Elshaier YAAM. Insight study for repurposing of certain anti-inflammatory drugs based on aspirin and salicylic acid scaffolds for the treatment of cancer as CDKs inhibitors: cheminformatics and anticancer studies. ChemistrySelect. 2025;10:e202500175 https:\/\/doi.org\/10.1002\/slct.202500175","journal-title":"ChemistrySelect"},{"key":"3610_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109157","volume":"166","author":"SY Ewieda","year":"2025","unstructured":"Ewieda SY, Ahmed EM, Gohar NA, Ibrahim SG, Essa MA, Nemr MT. Design, synthesis, and antitumor evaluation of new pyridazinone scaffolds as dual EGFR\/VEGFR-2 kinase inhibitors and apoptotic cells inducers. Bioorg Chem. 2025;166:109157 https:\/\/doi.org\/10.1016\/j.bioorg.2025.109157","journal-title":"Bioorg Chem"},{"key":"3610_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108672","volume":"163","author":"SY Ewieda","year":"2025","unstructured":"Ewieda SY, Salem MM, Elshewy A, Abdalla M, El-Manawaty M, Abdelhady HK, et al. Discovery of novel thiazolopyrimidine derivatives targeting topoisomerase II: Design, synthesis, antiproliferative evaluation, molecular docking and apoptosis inducing activity. Bioorg Chem. 2025;163:108672 https:\/\/doi.org\/10.1016\/j.bioorg.2025.108672","journal-title":"Bioorg Chem"},{"key":"3610_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0304-3835(01)00382-2","volume":"165","author":"MH Pourgholami","year":"2001","unstructured":"Pourgholami MH, Woon L, Almajd R, Akhter J, Bowery P, Morris DL. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett. 2001;165:43\u201349. https:\/\/doi.org\/10.1016\/S0304-3835(01)00382-2","journal-title":"Cancer Lett"},{"key":"3610_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bcp.2007.05.006","volume":"74","author":"A Khalilzadeh","year":"2007","unstructured":"Khalilzadeh A, Wangoo KT, Morris DL, Pourgholami MH. Epothilone-paclitaxel resistant leukemic cells CEM\/dEpoB300 are sensitive to albendazole: Involvement of apoptotic pathways. Biochem Pharmacol. 2007;74:407\u201314. https:\/\/doi.org\/10.1016\/j.bcp.2007.05.006","journal-title":"Biochem Pharmacol"},{"key":"3610_CR11","first-page":"3791","volume":"29","author":"SW Chu","year":"2009","unstructured":"Chu SW, Badar S, Morris DL, Pourgholami MH. Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole. Anticancer Res. 2009;29:3791\u20136.","journal-title":"Anticancer Res"},{"key":"3610_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1748-717X-6-160","volume":"6","author":"K Patel","year":"2011","unstructured":"Patel K, Doudican NA, Schiff PB, Orlow SJ. Albendazole sensitizes cancer cells to ionizing radiation. Radiation Oncol. 2011;6:160 https:\/\/doi.org\/10.1186\/1748-717X-6-160","journal-title":"Radiation Oncol"},{"key":"3610_CR13","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1182\/blood-2009-09-243055","volume":"115","author":"PA Spagnuolo","year":"2010","unstructured":"Spagnuolo PA, Hu J, Hurren R, Wang X, Gronda M, Sukhai MA, et al. The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma. Blood. 2010;115:4824\u201333. https:\/\/doi.org\/10.1182\/blood-2009-09-243055","journal-title":"Blood"},{"key":"3610_CR14","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1200\/JCO.2017.73.7585","volume":"35","author":"GW Sledge Jr","year":"2017","unstructured":"Sledge GW Jr, Toi M, Neven P, Sohn J, Inoue K, Pivot X, et al. MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+\/HER2- advanced breast cancer who had progressed while receiving endocrine therapy. J Clin Oncol. 2017;35:2875\u201384. https:\/\/doi.org\/10.1200\/JCO.2017.73.7585","journal-title":"J Clin Oncol"},{"key":"3610_CR15","doi-asserted-by":"publisher","first-page":"18593","DOI":"10.1039\/d5ra01077b","volume":"5","author":"B Farag","year":"2025","unstructured":"Farag B, Zaki MEA, Elsayed DA, Gomha SM. Benzimidazole chemistry in oncology: recent developments in synthesis, activity, and SAR analysis. RSC Adv. 2025;5:18593\u2013647. https:\/\/doi.org\/10.1039\/d5ra01077b","journal-title":"RSC Adv"},{"key":"3610_CR16","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1039\/d4ra05014b","volume":"15","author":"N Wagih","year":"2025","unstructured":"Wagih N, Abdel-Rahman IM, El-Koussi NA, Abuo-Rahma GEDA. Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article. RSC Adv. 2025;15:966\u20131010. https:\/\/doi.org\/10.1039\/d4ra05014b","journal-title":"RSC Adv"},{"key":"3610_CR17","doi-asserted-by":"publisher","unstructured":"Narasimhan B, Sapra A Benzimidazole derivatives as anticancer agents: A review of recent literature and structure-activity relationships. Lett Drug Des Discov 2026;100237. https:\/\/doi.org\/10.1016\/j.lddd.2025.100237","DOI":"10.1016\/j.lddd.2025.100237"},{"key":"3610_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300261","volume":"18","author":"L Racan\u0435","year":"2023","unstructured":"Racan\u0435 L, Zlati\u0441 K, Cindri\u0441 M, Mehi\u0441 E, Karminski-Zamola G, Taylor MC, et al. Synthesis and biological activity of 2-Benzo[b]thienyl and 2-Bithienyl amidino-substituted benzothiazole and benzimidazole derivatives. ChemMedChem. 2023;18:e202300261 https:\/\/doi.org\/10.1002\/cmdc.202300261","journal-title":"ChemMedChem"},{"key":"3610_CR19","doi-asserted-by":"publisher","first-page":"15843","DOI":"10.3390\/ijms232415843","volume":"23","author":"VR Kauli\u0441","year":"2022","unstructured":"Kauli\u0441 VR, Racan\u0435 L, Leventic M, Subaric D, Rastija V, Glavas-Obrovac L, et al. Synthesis, antiproliferative evaluation and QSAR analysis of novel halogenand amidino-substituted benzothiazoles and benzimidazoles. Int J Mol Sci. 2022;23:15843 https:\/\/doi.org\/10.3390\/ijms232415843","journal-title":"Int J Mol Sci"},{"key":"3610_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"3610_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.17116\/molgen201937041151","volume":"37","author":"IN Lyapun","year":"2019","unstructured":"Lyapun IN, Andryukov BG, Bynina MP. Hela cell culture: Henrietta Lacks immortal Heritage. Mol Genet Microbiol Virol. 2019;37:151\u20137. https:\/\/doi.org\/10.17116\/molgen201937041151","journal-title":"Mol Genet Microbiol Virol"},{"key":"3610_CR22","doi-asserted-by":"publisher","unstructured":"Van Meerloo J, Kaspers GJ, Cloos J Cell sensitivity assays: the MTT assay. Cancer cell culture: methods and protocols. Totowa: Humana press; 2011. pp. 237-45. https:\/\/doi.org\/10.1007\/978-1-61779-080-5_20","DOI":"10.1007\/978-1-61779-080-5_20"},{"key":"3610_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300261","volume":"18","author":"L Racane","year":"2023","unstructured":"Racane L, Zlatic K, Cindric M, Mehic E, Karminski\u2010Zamola G, Taylor MC, et al. Synthesis and biological activity of 2\u2010Benzo [b] thienyl and 2\u2010Bithienyl amidino\u2010substituted benzothiazole and benzimidazole derivatives. ChemMedChem. 2023;18:e202300261 https:\/\/doi.org\/10.1002\/cmdc.202300261","journal-title":"ChemMedChem"},{"key":"3610_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0005-2760(78)90005-X","volume":"530","author":"DL Shapiro","year":"1978","unstructured":"Shapiro DL, Nardone LL, Rooney SA, Motoyama EK, Munoz JL. Phospholipid biosynthesis and secretion by a cell line (A549) which resembles type II alveolar epithelial cells. Biochimica et Biophysica Acta (BBA)-Lipids Lipid Metab. 1978;530:197\u2013207. https:\/\/doi.org\/10.1016\/0005-2760(78)90005-X","journal-title":"Biochimica et Biophysica Acta (BBA)-Lipids Lipid Metab"},{"key":"3610_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdc.2023.100994","volume":"44","author":"PK Bandaru","year":"2023","unstructured":"Bandaru PK, Rao NS, Radhika G, Rao BV. Synthesis of amide derivatives of benzimidazole-isoxazoles as anticancer agents. Chem Data Collect. 2023;44:100994 https:\/\/doi.org\/10.1016\/j.cdc.2023.100994","journal-title":"Chem Data Collect"},{"key":"3610_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jss.2007.04.021","volume":"147","author":"A Rajput","year":"2008","unstructured":"Rajput A, San Martin ID, Rose R, Beko A, LeVea C, Sharratt E, et al. Characterization of HCT116 human colon cancer cells in an orthotopic model. J Surg Res. 2008;147:276\u201381. https:\/\/doi.org\/10.1002\/cmdc.202300261","journal-title":"J Surg Res"},{"key":"3610_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202403350","volume":"10","author":"S Messaoudi","year":"2025","unstructured":"Messaoudi S, Alminderej FM, Almuhaylan HR, Alosaimi AH, Almahmoud AS, Alfaifi MY, et al. In vitro and in silico evaluation of anticancer potential and apoptotic activity of benzimidazole\u2010based compounds. ChemistrySelect. 2025;10:e202403350 https:\/\/doi.org\/10.1002\/slct.202403350","journal-title":"ChemistrySelect"},{"key":"3610_CR28","doi-asserted-by":"publisher","unstructured":"Fogh J, Trempe G New human tumor cell lines. In: Fogh, J (eds), Human tumor cells in vitro. Boston: Springer US; 1975. pp. 115-59. https:\/\/doi.org\/10.1007\/978-1-4757-1647-4_5","DOI":"10.1007\/978-1-4757-1647-4_5"},{"key":"3610_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400930","volume":"358","author":"HE Bostanc\u0131","year":"2025","unstructured":"Bostanc\u0131 HE, Y\u0131ld\u0131z MT, Kapanc\u0131k S, \u015eahin Inan ZD, K\u0131l\u0131\u00e7 HA, \u00d6zensoy G\u00fcler \u00d6, et al. New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies. Arch Pharm (Weinheim). 2025;358:e2400930 https:\/\/doi.org\/10.1002\/ardp.202400930","journal-title":"Arch Pharm (Weinheim)"},{"key":"3610_CR30","doi-asserted-by":"publisher","unstructured":"Bostanc\u0131 HE, Maryam Z, Kapavarapu R, Bal H, Bagc\u0131 ER, Celik FK, et al. Synthesis and in silico study of novel benzimidazole derivatives bearing oxadiazole moiety as potential carbonic anhydrase inhibitors, anticancer and antioxidant agents. J Mol Struct 2025;142750. https:\/\/doi.org\/10.1016\/j.molstruc.2025.142750","DOI":"10.1016\/j.molstruc.2025.142750"},{"key":"3610_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","volume":"45","author":"CB Lozzio","year":"1975","unstructured":"Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975;45:321\u201334. https:\/\/doi.org\/10.1182\/blood.V45.3.321.321","journal-title":"Blood"},{"key":"3610_CR32","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1039\/D5MD00106D","volume":"16","author":"I Sokol","year":"2025","unstructured":"Sokol I, Rakas A, Grgi\u0107 DK, Persoons L, Daelemans D, Kraljevic TG. Biological assessments of novel ultrasound-synthesized 2-arylbenzimidazole derivatives: antiproliferative and antibacterial effects. RSC Med Chem. 2025;16:3197\u2013212. https:\/\/doi.org\/10.1039\/D5MD00106D","journal-title":"RSC Med Chem"},{"key":"3610_CR33","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.3390\/ijms25042288","volume":"25","author":"N Perin","year":"2024","unstructured":"Perin N, Gulin M, Kos M, Persoons L, Daelemans D, Fabijanic I, et al. Synthesis and biological evaluation of novel amino and amido substituted pentacyclic benzimidazole derivatives as antiproliferative agents. Int J Mol Sci. 2024;25:2288 https:\/\/doi.org\/10.3390\/ijms25042288","journal-title":"Int J Mol Sci"},{"key":"3610_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J","volume":"18","author":"GE Foley","year":"1965","unstructured":"Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. 1965;18:522\u20139. 10.1002\/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J","journal-title":"Cancer."},{"key":"3610_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107284","volume":"146","author":"HG Abdulwahab","year":"2024","unstructured":"Abdulwahab HG, Mansour RES, Farghaly TA, El-Sehrawi HM. Discovery of novel benzimidazole derivatives as potent HDACs inhibitors against leukemia with (Thio) Hydantoin as zinc-binding moiety: Design, synthesis, enzyme inhibition, and cellular mechanistic study. Bioorg Chem. 2024;146:107284 https:\/\/doi.org\/10.1016\/j.bioorg.2024.107284","journal-title":"Bioorg Chem"},{"key":"3610_CR36","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/jnci\/51.5.1409","volume":"51","author":"HD Soule","year":"1973","unstructured":"Soule HD, Vazquez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973;51:1409\u201316. https:\/\/doi.org\/10.1093\/jnci\/51.5.1409","journal-title":"J Natl Cancer Inst"},{"key":"3610_CR37","doi-asserted-by":"publisher","unstructured":"Shirazi FH, Zarghi A, Kobarfard F, Zendehdel R, Nakhjavani M, Arfaiee S, et al. Remarks in successful cellular investigations for fighting breast cancer using novel synthetic compounds. Breast Cancer-Focusing Tumor Microenviron Stem Cells Metastasis. 2011;85-102. https:\/\/doi.org\/10.5772\/23005","DOI":"10.5772\/23005"},{"key":"3610_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101718","volume":"10","author":"VN Kumar","year":"2024","unstructured":"Kumar VN, Nookaraju M, Jella KS, Eppakayala L. Rational design, synthesis, and anti-cancer evaluation of amide derivatives of 1, 3, 4-Thiadiazole benzimidazoles. Results Chem. 2024;10:101718 https:\/\/doi.org\/10.1016\/j.rechem.2024.101718","journal-title":"Results Chem"},{"key":"3610_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/jnci\/53.3.661","volume":"53","author":"R Cailleau","year":"1974","unstructured":"Cailleau R, Young R, Olive M, Reeves WJ Jr. Breast tumor cell lines from pleural effusions. J Natl Cancer Inst. 1974;53:661\u201374. https:\/\/doi.org\/10.1093\/jnci\/53.3.661","journal-title":"J Natl Cancer Inst"},{"key":"3610_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138189","volume":"1309","author":"XJ Wang","year":"2024","unstructured":"Wang XJ, Hou X, Zhang LY, Wang BY, Wu MY, Chen HJ, et al. Design, synthesis, and antitumor activity of benzimidazole derivatives as CDK4\/6 inhibitors. J Mol Struct. 2024;1309:138189 https:\/\/doi.org\/10.1016\/j.molstruc.2024.138189","journal-title":"J Mol Struct"},{"key":"3610_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/282615a0","volume":"282","author":"DP Aden","year":"1979","unstructured":"Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature. 1979;282:615\u20136. https:\/\/doi.org\/10.1038\/282615a0","journal-title":"Nature"},{"key":"3610_CR42","doi-asserted-by":"publisher","first-page":"13135","DOI":"10.3390\/ijms222313135","volume":"22","author":"VA Arzumanian","year":"2011","unstructured":"Arzumanian VA, Kiseleva OI, Poverennaya EV. The curious case of the HepG2 cell line: 40 years of expertise. Int J Mol Sci. 2011;22:13135 https:\/\/doi.org\/10.3390\/ijms222313135","journal-title":"Int J Mol Sci"},{"key":"3610_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5505\/vmj.2025.58077","volume":"32","author":"E Bilici","year":"2025","unstructured":"Bilici E, Akkoc S. Investigation of the cytotoxic effect of a new N-Phenyl benzimidazole derivative on cell viability in A549 and HepG2 cell lines. Van Tip Dergisi. 2025;32:3\u20136. https:\/\/doi.org\/10.5505\/vmj.2025.58077","journal-title":"Van Tip Dergisi"},{"key":"3610_CR44","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro Oncol. 2020;22:iv1\u2013iv96. https:\/\/doi.org\/10.1093\/neuonc\/noaa200","journal-title":"Neuro Oncol"},{"key":"3610_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/stmcls\/sxac088","volume":"41","author":"H Yan","year":"2023","unstructured":"Yan H, Zhu J, Ping Y, Yan M, Liao G, Yuan H, et al. The heterogeneous cellular states of glioblastoma stem cells revealed by single-cell analysis. Stem Cells. 2023;41:111\u201325. https:\/\/doi.org\/10.1093\/stmcls\/sxac088","journal-title":"Stem Cells"},{"key":"3610_CR46","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1158\/0008-5472.CAN-23-0609","volume":"84","author":"X Guo","year":"2024","unstructured":"Guo X, Qiu W, Wang C, Qi Y, Li B, Wang S, et al. Neuronal activity promotes glioma progression by inducing proneural-to-mesenchymal transition in glioma stem cells. Cancer Res. 2024;84:372\u201387. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0609","journal-title":"Cancer Res"},{"key":"3610_CR47","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","volume":"3","author":"SY Lee","year":"2016","unstructured":"Lee SY. Temozolomide resistance in glioblastoma multiforme. Genes Dis. 2016;3:198\u2013210. https:\/\/doi.org\/10.1016\/j.gendis.2016.04.007","journal-title":"Genes Dis"},{"key":"3610_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.143865","volume":"1349","author":"R Bhukya","year":"2026","unstructured":"Bhukya R, Vanga MK, Thumma V, Mudiraj A, Ranjan N, Phanithi PB, et al. Synthesis of quinoline based benzimidazole\u20131, 2, 3-triazole hybrids: In vitro anti-proliferative activity and docking studies. J Mol Struct. 2026;1349:143865 https:\/\/doi.org\/10.1016\/j.molstruc.2025.143865","journal-title":"J Mol Struct"},{"key":"3610_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2024.133940","volume":"156","author":"HTB Bui","year":"2024","unstructured":"Bui HTB, Do KM, Hong QV, Le HT, Hnin SYY, Tran DQ, et al. Solvent-free strategy for facile synthesis and cytotoxicity evaluation of benzimidazole derivatives. Tetrahedron. 2024;156:133940 https:\/\/doi.org\/10.1016\/j.tet.2024.133940","journal-title":"Tetrahedron"},{"key":"3610_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13065-025-01532-z","volume":"19","author":"N Senthilkumar","year":"2025","unstructured":"Senthilkumar N, Sarveswari S, Choudhari P, Chaudhari S, Islam I, Tamboli Y, et al. Novel benzimidazole-1,3,4-thiadiazole derivatives as casein kinase-2 inhibitors: synthesis, in vitro and in silico investigations. BMC Chem. 2025;19:161 https:\/\/doi.org\/10.1186\/s13065-025-01532-z","journal-title":"BMC Chem"},{"key":"3610_CR51","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1134\/S1070363224611293","volume":"95","author":"P Naresh","year":"2025","unstructured":"Naresh P, Hemasri Y, Limbadri P, Rao YJ. Synthesis of Novel Substituted 4-[1-(1-Phenyl-1 H-[1, 2, 3] triazol-4-yl-methyl)-1 H-benzimidazol-2-yl] piperidine-1-carboxylic Acids tert-Butyl Esters. Evaluation of Cytotoxic and Antimicrobial Activity. Russ J Gen Chem. 2025;95:538\u201347. https:\/\/doi.org\/10.1134\/S1070363224611293","journal-title":"Russ J Gen Chem"},{"key":"3610_CR52","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1134\/S1070428024604679","volume":"61","author":"EV Koroleva","year":"2025","unstructured":"Koroleva EV, Ermolinskaya AL, Ignatovich ZV, Panibrat OV, Hoang TKD, Huynh TKC, et al. Synthesis and Antiproliferative Activity of 4-(1 H-Benzimidazol-2-yl)-N-{3-[(pyrimidin-2-yl) amino] phenyl} benzamides as Potential Protein Kinase Inhibitors. Russ J Org Chem. 2025;61:378\u201384. https:\/\/doi.org\/10.1134\/S1070428024604679","journal-title":"Russ J Org Chem"},{"key":"3610_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.137020","volume":"1298","author":"NA Nawareg","year":"2024","unstructured":"Nawareg NA, Mostafa AS, El-Messery SM, Nasr MN. Benzimidazole based hybrids as privileged candidates for topoII inhibition: Design, synthesis and molecular modeling studies. J Mol Struct. 2024;1298:137020 https:\/\/doi.org\/10.1016\/j.molstruc.2023.137020","journal-title":"J Mol Struct"},{"key":"3610_CR54","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1134\/S1068162024040307","volume":"50","author":"B Karthik","year":"2024","unstructured":"Karthik B, Ramakrishna B, Kumar BA, Kumar TK. Design and synthesis of some new benzimidazole-1,2,3-triazole-thiazolidine-2,4-dione conjugates as tubulin polymerization inhibitors. Russ J Bioorg Chem. 2024;50:1434\u201345. https:\/\/doi.org\/10.1134\/S1068162024040307","journal-title":"Russ J Bioorg Chem"},{"key":"3610_CR55","doi-asserted-by":"publisher","first-page":"6950","DOI":"10.3390\/molecules28196950","volume":"28","author":"L Krstulovic","year":"2023","unstructured":"Krstulovic L, Miskovic Spoljaric K, Rastija V, Filipovic N, Bajic M, Glavas-Obrovac L. Novel 1, 2, 3-triazole-containing quinoline\u2013benzimidazole hybrids: Synthesis, antiproliferative activity, in silico ADME predictions, and docking. Molecules. 2023;28:6950 https:\/\/doi.org\/10.3390\/molecules28196950","journal-title":"Molecules"},{"key":"3610_CR56","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s11696-024-03861-0","volume":"79","author":"ER Devi","year":"2025","unstructured":"Devi ER, Sravani D, Alkhathami AG, Suresh P, Sreenivasulu R, Malladi S, et al. Design, synthesis, in-vitro and in-silico anticancer studies on amide derivatives of 1, 3, 4-oxadiazole-isoxazol-pyridine-benzimidazole. Chem Pap. 2025;79:1385\u2013405. https:\/\/doi.org\/10.1007\/s11696-024-03861-0","journal-title":"Chem Pap"},{"key":"3610_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202500813","volume":"10","author":"MA Soliman","year":"2025","unstructured":"Soliman MA, Eltamany EH, Boraei AT, Aouad MR, Aljuhani A, Almohaywi B, et al. Novel Benzimidazole\u20101,2,3\u2010Triazole hybrids: synthesis, dual antimicrobial, anticancer activity, mechanistic insights, and computational studies. ChemistrySelect. 2025;10:e202500813 https:\/\/doi.org\/10.1002\/slct.202500813","journal-title":"ChemistrySelect"},{"key":"3610_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22218","volume":"85","author":"U Acar \u00c7evik","year":"2024","unstructured":"Acar \u00c7evik U, Celik I, G\u00f6rg\u00fcl\u00fc S, \u015eahin Inan ZD, Bostanc\u0131 HE, \u00d6zkay Y, et al. New benzimidazole\u2010oxadiazole derivatives as potent VEGFR\u20102 inhibitors: Synthesis, anticancer evaluation, and docking study. Drug Dev Res. 2024;85:e22218 https:\/\/doi.org\/10.1002\/ddr.22218","journal-title":"Drug Dev Res"},{"key":"3610_CR59","doi-asserted-by":"publisher","first-page":"6801","DOI":"10.1021\/acsomega.4c08885","volume":"10","author":"UA \u00c7evik","year":"2025","unstructured":"\u00c7evik UA, Celik I, Gorgulu S, S\u0327ahin I\u0307nan ZD, Bostanc\u0131 HE, Karayel A, et al. Novel benzimidazole\u2010oxadiazole derivatives as anticancer agents with VEGFR2 inhibitory activity: design, synthesis, in vitro anticancer evaluation, and in silico studies. ACS Omega. 2025;10:6801\u201313. https:\/\/doi.org\/10.1021\/acsomega.4c08885","journal-title":"ACS Omega"},{"key":"3610_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202401797","volume":"9","author":"P Sabale","year":"2024","unstructured":"Sabale P, Sayyad N, Sabale V, Begum T, Murali Prakash J, Gobalakriahnan P, et al. Molecular docking, synthesis and biological evaluation of new benzimidazole\u2010pyridine derivatives as potential aromatase inhibitor for the treatment of cancer. ChemistrySelect. 2024;9:e202401797 https:\/\/doi.org\/10.1002\/slct.202401797","journal-title":"ChemistrySelect"},{"key":"3610_CR61","doi-asserted-by":"publisher","first-page":"35323","DOI":"10.1039\/d4ra04492d","volume":"14","author":"N Dastyafteh","year":"2024","unstructured":"Dastyafteh N, Negahdaripour M, Sayahi MH, Emami M, Ghasemi Y, Safaei E, et al. Design, synthesis, biological evaluation, and in silico studies of novel N-substituted-2-(3, 4, 5-trimethoxyphenyl)-1 H-benzo [d] imidazole-6-carboxamides as promising anticancer agents. RSC Adv. 2024;14:35323\u201335. https:\/\/doi.org\/10.1039\/d4ra04492d","journal-title":"RSC Adv"},{"key":"3610_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.17776\/csj.1392037","volume":"45","author":"AZ Kaya","year":"2024","unstructured":"Kaya AZ, Osmaniye D, Evren AE, Yurtta\u015f L, Demirayak S. Synthesis, cytotoxic activity evaluation and molecular docking studies of some benzimidazole derivatives. Cumhur Sci J. 2024;45:80\u201387. https:\/\/doi.org\/10.17776\/csj.1392037","journal-title":"Cumhur Sci J"},{"key":"3610_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202304716","volume":"9","author":"S Demirci","year":"2024","unstructured":"Demirci S, K\u00f6pr\u00fcl\u00fc TK, Mermer A, Y\u0131lmaz GT. Synthesis, biological investigation, and molecular docking of novel benzimidazole\u2010hydrazone hybrids as potential anticancer agent candidates. ChemistrySelect. 2024;9:e202304716 https:\/\/doi.org\/10.1002\/slct.202304716","journal-title":"ChemistrySelect"},{"key":"3610_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116106","volume":"171","author":"SJ Park","year":"2024","unstructured":"Park SJ, Song IH, Yeom GS, Nimse SB. The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo [d] imidazole derivatives as potential anticancer agents. Biomed Pharmacother. 2024;171:116106 https:\/\/doi.org\/10.1016\/j.biopha.2023.116106","journal-title":"Biomed Pharmacother"},{"key":"3610_CR65","doi-asserted-by":"publisher","first-page":"37447","DOI":"10.1039\/d5ra02760h","volume":"15","author":"ASS Asl","year":"2025","unstructured":"Asl ASS, Ranjbar S, Sayahi MH, Dehghani Z, Taherkhani AM, Negahdaripour M, et al. Synthesis, biological evaluation, and docking analysis of novel benzimidazole\u2010triazole hybrids as potential anticancer agents. RSC Adv. 2025;15:37447\u201360. https:\/\/doi.org\/10.1039\/d5ra02760h","journal-title":"RSC Adv"},{"key":"3610_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2023.129494","volume":"96","author":"K Laxmikeshav","year":"2023","unstructured":"Laxmikeshav K, Rahman Z, Mahale A, Valapil DG, Sharma P, George J, et al. Benzimidazole derivatives as tubulin polymerization inhibitors: design, synthesis and in vitro cytotoxicity studies. Bioorg Med Chem Lett. 2023;96:129494 https:\/\/doi.org\/10.1016\/j.bmcl.2023.129494","journal-title":"Bioorg Med Chem Lett"},{"key":"3610_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdc.2023.101008","volume":"45","author":"P Rajendar","year":"2023","unstructured":"Rajendar P, Srinivasadesikan V, Tripuramallu BK. Synthesis and biological evolution of aryl quinolin-benzimidazole-1, 2, 3-triazole as anticancer agents. Chem Data Collect. 2023;45:101008 https:\/\/doi.org\/10.1016\/j.cdc.2023.101008","journal-title":"Chem Data Collect"},{"key":"3610_CR68","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13065-023-01003-3","volume":"17","author":"FF Hagar","year":"2023","unstructured":"Hagar FF, Abbas SH, Gomaa HA, Youssif BG, Sayed AM, Abdelhamid D, et al. Chalcone\/1, 3, 4-Oxadiazole\/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E. BMC Chem. 2023;17:116 https:\/\/doi.org\/10.1186\/s13065-023-01003-3","journal-title":"BMC Chem"},{"key":"3610_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/open.202500263","volume":"14","author":"SS Uthumange","year":"2025","unstructured":"Uthumange SS, Zaki MAFBA, Yeong KY. Synthesis and anticancer potential of new benzimidazole theranostic. ChemistryOpen. 2025;14:e202500263 https:\/\/doi.org\/10.1002\/open.202500263","journal-title":"ChemistryOpen"},{"key":"3610_CR70","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00706-025-03371-z","volume":"156","author":"GY Erdemir","year":"2025","unstructured":"Erdemir GY, Gunduz N, Ates B, Altundas A. Novel 1, 2, 3-triazole-benzimidazole hybrid structures acting as promising anticancer agents against breast and colon cancer cell. Monatshefte f\u00fcr Chemie-Chemical Monthly. 2025;156:1217\u201326. https:\/\/doi.org\/10.1007\/s00706-025-03371-z","journal-title":"Monatshefte f\u00fcr Chemie-Chemical Monthly"},{"key":"3610_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.108112","volume":"154","author":"S Thakur","year":"2025","unstructured":"Thakur S, Prashar M, Sharma R, Sahoo SC, Wangoo N, Dhingra N, et al. Synthesis, X-ray, antioxidant, in-vitro biological & in-silico docking studies of novel organoselenides: Promising colorectal cancer inhibitors. Bioorg Chem. 2025;154:108112 https:\/\/doi.org\/10.1016\/j.bioorg.2024.108112","journal-title":"Bioorg Chem"},{"key":"3610_CR72","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.3390\/molecules29092138","volume":"29","author":"A Bec","year":"2024","unstructured":"Bec A, Zlatic K, Banjanac M, Radovanovic V, Starcevic K, Kralj M, et al. Design, synthesis and biological activity of novel methoxy-and hydroxy-substituted N-benzimidazole-derived carboxamides. Molecules. 2024;29:2138 https:\/\/doi.org\/10.3390\/molecules29092138","journal-title":"Molecules"},{"key":"3610_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2023.101134","volume":"6","author":"RB Shinde","year":"2024","unstructured":"Shinde RB, Pansare DN, Shelke RN, Sarkate AP, Tiwari SV, Bangal MN, et al. A facile synthesis and characterization of some novel benzimidazole derivatives. Results Chem. 2024;6:101134 https:\/\/doi.org\/10.1016\/j.rechem.2023.101134","journal-title":"Results Chem"},{"key":"3610_CR74","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2166037","volume":"38","author":"DI Othman","year":"2023","unstructured":"Othman DI, Hamdi A, Tawfik SS, Elgazar AA, Mostafa AS. Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies. J Enzyme Inhib Med Chem. 2023;38:2166037 https:\/\/doi.org\/10.1080\/14756366.2023.2166037","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3610_CR75","doi-asserted-by":"publisher","first-page":"36134","DOI":"10.1021\/acsomega.5c03795","volume":"10","author":"G Halimi Syla","year":"2025","unstructured":"Halimi Syla G, Osmaniye D, Korkut C\u0327elikates\u0327 B, Ozkay Y, Kaplanc\u0131kl\u0131 ZA. Targeting cancer with new morpholine-benzimidazole-oxadiazole derivatives: synthesis, biological evaluation, and computational insights. ACS Omega. 2025;10:36134\u201353. https:\/\/doi.org\/10.1021\/acsomega.5c03795","journal-title":"ACS Omega"},{"key":"3610_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202304958","volume":"9","author":"K Chandrakar","year":"2025","unstructured":"Chandrakar K, Sureddy NK, Chedupaka R, Papisetti V, Mahapatra SP, Penta S. Synthesis of benzimidazole based 1,2,4\u2010triazole derivatives as potential anticancer agents: in silico techniques. ChemistrySelect. 2025;9:e202304958 https:\/\/doi.org\/10.1002\/slct.202304958","journal-title":"ChemistrySelect"},{"key":"3610_CR77","doi-asserted-by":"publisher","first-page":"108","DOI":"10.22034\/jchemlett.2024.485047.1236","volume":"6","author":"V Manga","year":"2025","unstructured":"Manga V, Aleti B, Patnam N, Chevula K, Chennamsetti P, Edigi P. Synthesis, anticancer evaluation and in-silico molecular docking studies of Benzimidazole-containing 1, 2,3-Triazoles. J Chem Lett. 2025;6:108\u201320. https:\/\/doi.org\/10.22034\/jchemlett.2024.485047.1236","journal-title":"J Chem Lett"},{"key":"3610_CR78","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.1021\/acsomega.4c09384","volume":"10","author":"A Choudhary","year":"2025","unstructured":"Choudhary A, Garge ND, Ala C, Patel B, Patel VP, Gurjar KK, et al. Metal-Free, visible-light-mediated synthesis of tetracyclic benzimidazole: regioselective C\u2013H functionalization with in vitro and computational study of anti-breast cancer compounds. ACS Omega. 2025;10:5778\u201394. https:\/\/doi.org\/10.1021\/acsomega.4c09384","journal-title":"ACS Omega"},{"key":"3610_CR79","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.62110\/sciencein.cbl.2025.v12.1271","volume":"12","author":"A Vanaparthya","year":"2025","unstructured":"Vanaparthya A, Thallapallyb KK, Banothuc D, Polkampallyd K, Kondrapolue RS, Nukalaf SK, et al. Synthesis and in vitro anti-EGFR screening of some new 1, 2, 3-triazole-benzimidazole hybrids and insilico studies. Chem Biol Lett. 2025;12:1271 https:\/\/doi.org\/10.62110\/sciencein.cbl.2025.v12.1271","journal-title":"Chem Biol Lett"},{"key":"3610_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202500883","volume":"10","author":"PS Singu","year":"2025","unstructured":"Singu PS, Nadagouda A, Kiranmai G, Mahadik NS, Ganapathi T, Sindhuja RH, et al. Studies on the anticancer potential and interaction of synthetic hydrazone and azole hybrids having 1H\u2010Benzo[d]imidazole\u20102\u2010thiol Moiety with G\u2010Quadruplex DNA. ChemistrySelect. 2025;10:e00883 https:\/\/doi.org\/10.1002\/slct.202500883","journal-title":"ChemistrySelect"},{"key":"3610_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.nexres.2025.100145","volume":"2","author":"KM Shaik","year":"2025","unstructured":"Shaik KM, Pandurangan K, Allaka TR, Ahmed MZ, Gunda SK. Synthesis and biological evaluation of novel benzo[d]imidazole bearing oxadiazolyl-triazole derivatives as potential anticancer agents: a computational docking technique. Next Res. 2025;2:100145 https:\/\/doi.org\/10.1016\/j.nexres.2025.100145","journal-title":"Next Res"},{"key":"3610_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s44446-025-00010-w","volume":"33","author":"LS Al-Rasheed","year":"2025","unstructured":"Al-Rasheed LS, Ansari SA, Asiri HH, Bakheit AH, Al-Mehizia AA, Alsegiani AS, et al. Design, synthesis, biological evaluation and in silico studies of 2-anilino-4-(benzimidazol-1-yl) pyrimidine scaffold as antitumor agents. Saudi Pharm J. 2025;33:12 https:\/\/doi.org\/10.1007\/s44446-025-00010-w","journal-title":"Saudi Pharm J"},{"key":"3610_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.143457","volume":"1348","author":"AM Mansour","year":"2025","unstructured":"Mansour AM, Radacki K, Shehab OR, Mostafa GA, Ali EA, Abo-Elfadl MT. Pd (II) complexes of 2, 6-bis (1-ethyl-benzimidazol-2\u2032-yl) pyridine and 4-((pyridin-2-ylmethylene) amino) aniline: antiproliferative properties and mechanism of action. J Mol Struct. 2025;1348:143457 https:\/\/doi.org\/10.1016\/j.molstruc.2025.143457","journal-title":"J Mol Struct"},{"key":"3610_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.110245","volume":"764","author":"M Argirova","year":"2025","unstructured":"Argirova M, Cherneva E, Mihaylova R, Momekov G, Yancheva D. New metal complexes of 1H-benzimidazole\u20102\u2010yl hydrazones: Cytostatic, proapoptotic and modulatory activity on kinase signaling pathways. Arch Biochem Biophys. 2025;764:110245 https:\/\/doi.org\/10.1016\/j.abb.2024.110245","journal-title":"Arch Biochem Biophys"},{"key":"3610_CR85","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/biom15030351","volume":"15","author":"M Piskor","year":"2025","unstructured":"Piskor M, Milic A, Kostrun S, Majeric Elenkov M, Grbcic P, Kraljevic Pavelic S, et al. Synthesis, antiproliferative activity, and ADME profiling of novel racemic and optically pure aryl-substituted purines and purine bioisosteres. Biomolecules. 2025;15:351 https:\/\/doi.org\/10.3390\/biom15030351","journal-title":"Biomolecules"},{"key":"3610_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.137960","volume":"1308","author":"S Gursoy","year":"2024","unstructured":"Gursoy S, Ersan RH. Diaryl-substituted benzimidazole derivatives as antiproliferative agents: Design, synthesis, in vitro activity, and SAR analysis. J Mol Struct. 2024;1308:137960 https:\/\/doi.org\/10.1016\/j.molstruc.2024.137960","journal-title":"J Mol Struct"},{"key":"3610_CR87","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1248\/cpb.c24-00570","volume":"72","author":"HTB Bui","year":"2024","unstructured":"Bui HTB, Htoo ZP, Hong QV, Le HT, Tran DQ, Hnin SYY, et al. Facile synthesis of 1, 2-Disubstituted benzimidazoles as potent cytotoxic agents. Chem Pharm Bull (Tokyo). 2024;72:944\u20139. https:\/\/doi.org\/10.1248\/cpb.c24-00570","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"3610_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138177","volume":"1309","author":"TO Mirgany","year":"2024","unstructured":"Mirgany TO, Rahman AM, Alanazi MM. Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2: Promising candidates for anticancer therapy. J Mol Struct. 2024;1309:138177 https:\/\/doi.org\/10.1016\/j.molstruc.2024.138177","journal-title":"J Mol Struct"},{"key":"3610_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400052","volume":"19","author":"AP Sakla","year":"2024","unstructured":"Sakla AP, Bazaz MR, Mahale A, Sharma P, Valapil DG, Kulkarni OP, et al. Development of benzimidazole\u2010substituted spirocyclopropyl oxindole derivatives as cytotoxic agents: tubulin polymerization inhibition and apoptosis inducing studies. ChemMedChem. 2024;19:e202400052 https:\/\/doi.org\/10.1002\/cmdc.202400052","journal-title":"ChemMedChem"},{"key":"3610_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114977","volume":"164","author":"IH Song","year":"2023","unstructured":"Song IH, Park SJ, Yeom GS, Song KS, Kim T, Nimse SB. Not all benzimidazole derivatives are microtubule destabilizing agents. Biomed Pharmacother. 2023;164:114977 https:\/\/doi.org\/10.1016\/j.biopha.2023.114977","journal-title":"Biomed Pharmacother"},{"key":"3610_CR91","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1134\/S1070428023050226","volume":"59","author":"K Ravi","year":"2023","unstructured":"Ravi K, Dhoddi BN, Pochampally J, Matta R. Synthesis of benzothiazole\/benzimidazole-conjugated imidazoles as anticancer agents and their molecular modeling. Russ J Org Chem. 2023;59:915\u201323. https:\/\/doi.org\/10.1134\/S1070428023050226","journal-title":"Russ J Org Chem"},{"key":"3610_CR92","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s11030-022-10481-x","volume":"27","author":"C Bagul","year":"2023","unstructured":"Bagul C, Rao GK, Veena I, Kulkarni R, Tamboli JR, Akunuri R, et al. Benzimidazole-linked pyrazolo [1, 5-a] pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents. Mol Divers. 2023;27:1185\u2013202. https:\/\/doi.org\/10.1007\/s11030-022-10481-x","journal-title":"Mol Divers"},{"key":"3610_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.136341","volume":"1294","author":"CE Theodore","year":"2023","unstructured":"Theodore CE, Sivaiah G, Prasad SB, Kumar KY, Raghu MS, Alharethy F, et al. Design, synthesis, anticancer activity and molecular docking of novel 1H-benzo [d] imidazole derivatives as potential EGFR inhibitors. J Mol Struct. 2023;1294:136341 https:\/\/doi.org\/10.1016\/j.molstruc.2023.136341","journal-title":"J Mol Struct"},{"key":"3610_CR94","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.3390\/ijms26125897","volume":"26","author":"P Winska","year":"2025","unstructured":"Winska P, Wielechowska M, Milewski L, Siedlecki P, Lukowska-Chojnacka E. Pro-Apoptotic activity of 1-(4, 5, 6, 7-Tetrabromo-1 H-benzimidazol-1-yl) propan-2-one, an intracellular inhibitor of PIM-1 Kinase in acute lymphoblastic leukemia and breast cancer cells. Int J Mol Sci. 2025;26:5897 https:\/\/doi.org\/10.3390\/ijms26125897","journal-title":"Int J Mol Sci"},{"key":"3610_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101631","volume":"9","author":"SB Srinivasa","year":"2024","unstructured":"Srinivasa SB, Poojary B, Kalal BS, Brahmavara U, Vaishali D, Das AJ, et al. Design, synthesis and anticancer activity of Novel benzimidazole containing quinoline hybrids. Results Chem. 2024;9:101631 https:\/\/doi.org\/10.1016\/j.rechem.2024.101631","journal-title":"Results Chem"},{"key":"3610_CR96","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s11030-023-10661-3","volume":"28","author":"S Gali","year":"2024","unstructured":"Gali S, Raghu D, Mallikanti V, Thumma V, Vaddiraju N. Design, synthesis of benzimidazole tethered 3, 4-dihydro-2H-benzo[e][1,3]oxazines as anticancer agents. Mol Divers. 2024;28:1347\u201361. https:\/\/doi.org\/10.1007\/s11030-023-10661-3","journal-title":"Mol Divers"},{"key":"3610_CR97","doi-asserted-by":"publisher","first-page":"28733","DOI":"10.1021\/acsomega.3c03530","volume":"8","author":"NKN Phan","year":"2023","unstructured":"Phan NKN, Huynh TKC, Nguyen HP, Le QT, Nguyen TCT, Ngo KKH, et al. Exploration of remarkably potential multitarget-directed N-alkylated-2-(substituted phenyl)-1 H-benzimidazole derivatives as antiproliferative, antifungal, and antibacterial agents. ACS Omega. 2023;8:28733\u201348. https:\/\/doi.org\/10.1021\/acsomega.3c03530","journal-title":"ACS Omega"},{"key":"3610_CR98","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s42250-024-00893-7","volume":"7","author":"I Bayar","year":"2024","unstructured":"Bayar I, Turkmenoglu B, Akkoc S. Biological and in silico studies on the benzimidazole-based compounds. Chemistry Africa. 2024;7:2345\u201352. https:\/\/doi.org\/10.1007\/s42250-024-00893-7","journal-title":"Chemistry Africa"},{"key":"3610_CR99","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3390\/ph16111518","volume":"16","author":"K Anichina","year":"2023","unstructured":"Anichina K, Mavrova A, Vuchev D, Popova-Daskalova G, Bassi G, Rossi A, et al. Benzimidazoles containing piperazine skeleton at c-2 position as promising tubulin modulators with anthelmintic and antineoplastic activity. Pharmaceuticals. 2023;16:1518 https:\/\/doi.org\/10.3390\/ph16111518","journal-title":"Pharmaceuticals"},{"key":"3610_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202302393","volume":"8","author":"S Ambala","year":"2023","unstructured":"Ambala S, Thumma V, Mallikanti V, Aitha S, Matta R, Pochampally J. Design, synthesis, and cytotoxicity of some new benzimidazole\u2010piperazine conjugate analogues against human breast adenocarcinoma. ChemistrySelect. 2023;8:e202302393 https:\/\/doi.org\/10.1002\/slct.202302393","journal-title":"ChemistrySelect"},{"key":"3610_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2023.101018","volume":"6","author":"R Champa","year":"2023","unstructured":"Champa R, Vishnumurthy KA, Bodke YD, Naik HB, Pushpavathi I, Meghana P, et al. Synthesis, characterization, and biological investigations of potentially bioactive heterocyclic compounds containing benzimidazole nucleus. Results Chem. 2023;6:101018 https:\/\/doi.org\/10.1016\/j.rechem.2023.101018","journal-title":"Results Chem"},{"key":"3610_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151024","volume":"741","author":"M Mavvaji","year":"2024","unstructured":"Mavvaji M, Zeyrek CT, Akkoc S. Investigation of the cytotoxic activity, DFT calculation, and docking studies newly synthesized 1, 3-disubstituted benzimidazolium chlorides on human liver cancer, lung cancer, and normal embryonic kidney cell lines. Biochem Biophys Res Commun. 2024;741:151024 https:\/\/doi.org\/10.1016\/j.bbrc.2024.151024","journal-title":"Biochem Biophys Res Commun"},{"key":"3610_CR103","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/jhet.70114","volume":"63","author":"GU Rao","year":"2026","unstructured":"Rao GU, Yerrabelly JR, Yerrabelly H, Valluru KR. Imidazo [1,2\u2010a] pyrazine linked benzimidazole, tetrahydropyrimidine, and 1,3,4\u2010Oxadizoles as anticancer agents. J Heterocycl Chem. 2026;63:60\u201371. https:\/\/doi.org\/10.1002\/jhet.70114","journal-title":"J Heterocycl Chem"},{"key":"3610_CR104","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1134\/S1070428024120212","volume":"60","author":"R Elrayess","year":"2024","unstructured":"Elrayess R, Elrayess R, Hussien K, Ghareb N. Benzimidazole derivatives as potential CDK2 inhibitors: synthesis, molecular docking, and antiproliferative investigations. Russ J Org Chem. 2024;60:2462\u201374. https:\/\/doi.org\/10.1134\/S1070428024120212","journal-title":"Russ J Org Chem"},{"key":"3610_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96675-3","volume":"15","author":"AM Srour","year":"2025","unstructured":"Srour AM, El-Bayaa MN, Temirak A, Alanzy AL, Awad HM, Saleh A, et al. New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors. Sci Rep. 2025;15:25514 https:\/\/doi.org\/10.1038\/s41598-025-96675-3","journal-title":"Sci Rep"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03610-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03610-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03610-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:04:04Z","timestamp":1788343444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03610-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":105,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3610"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03610-w","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this paper declare that no generative AI and AI-assisted technologies were used during the preparation of this review.","order":1,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}